September 25, 2020

The Niche

Knoepfler lab stem cell blog

Camillo Ricordi

5 min read

The term Regenerative Medicine covers so much biomedical science these days including everything from just about any kind of cell therapy (not just stem cells) to CRISPR gene editing, and with the the COVID-19 pandemic, it seems this umbrella use of the term now includes potential treatment of viral illnesses. It can be hard to keep track of it all. I’m regularly doing a kind of “regenerative medicine” digest these days to help. Today’s post is just such an aggregate with a focus on …Read More

10 min read

The idea of testing stem cells for COVID-19 may be music to the ears of some folks as an opportunity, but to me from the beginning it sounded mostly like a spaghetti on the wall road to trouble. There is buzz out there that some kind of stem cells or other cells will help with COVID-19. The reality is that that’s probably not going to happen. Even so, a whole range of people and firms are somewhat exaggerating and in a few cases outright …Read More

3 min read

I recently posted on the dangerous situation with the Stamina Foundation. I discussed the controversy surrounding it that has impacted scientists, politicians, the media, and patients. Stamina’s unproven stem cell treatments in Italy should be of concern to everyone across the globe in the stem cell field. For example, here in the US where I live, there are similar things going on to Stamina too. I asked Professor Michele Simonato, MD of the University of Ferrara, Italy, who is very familiar with the Stamina …Read More

3 min read

One of the big stem cell-related stories of 2013 was the controversy over the Stamina Foundation in Italy and its potential use of largely untested stem cell products on patients, including mostly children. The winner of my 2013 Stem Cell Person of the Year Award was Dr. Elena Cattaneo and one reason she won was the courage she had in standing up to Stamina. Today’s post is Part 1 of at least 2 in a blog series on Stamina. The Stamina controversy continues in 2014. You …Read More